Gregory P. Lewis
Known title: DirectorCIK: 0001748656
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Honeywell Q3 Earnings Expected to Decline. Honeywell’s upcoming third‑quarter earnings are projected to fall short of previous results. Analysts point out that the company’s long‑term outlook still looks appealing. A recent comparison article suggests Honeywell may be a stronger choice than Corning for 2026.
Transaction History
| MDT | ▼ Sell | Tax Withholding | 207 | $17K | 4/28/2026 | View on chart |
| MDT | ▲ Buy | Grant | 2,111 | $0 | 4/27/2026 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 181 | $15K | 4/29/2025 | View on chart |
| MDT | ▲ Buy | Grant | 2,083 | $175K | 4/28/2025 | View on chart |
| HON | ▼ Sell | Tax Withholding | 3,773 | $777K | 2/13/2025 | View on chart |
| HON | ▲ Buy | Grant | 8,653 | $0 | 2/13/2025 | View on chart |
| HON | ▼ Sell | Tax Withholding | 530 | $109K | 2/12/2025 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,215 | — | 2/12/2025 | View on chart |
| HON | ▲ Buy | Option Exercise | 2,358 | — | 2/10/2025 | View on chart |
| HON | ▼ Sell | Tax Withholding | 1,043 | $216K | 2/10/2025 | View on chart |
| HON | ▲ Buy | Option Exercise | 26,110 | $3.1M | 10/29/2024 | View on chart |
| HON | ▼ Sell | Tax Withholding | 26,110 | $7.7M | 10/29/2024 | View on chart |
| HON | ▲ Buy | Option Exercise | 25,209 | $2.5M | 4/29/2024 | View on chart |
| MDT | ▲ Buy | Grant | 1,821 | $147K | 4/29/2024 | View on chart |
| HON | ▼ Sell | Gift | 1,151 | $0 | 4/29/2024 | View on chart |
| HON | ▼ Sell | Open Market | 25,209 | $4.9M | 4/29/2024 | View on chart |
| HON | ▲ Buy | Grant | 8,499 | $0 | 2/16/2024 | View on chart |
| HON | ▼ Sell | Tax Withholding | 3,777 | $744K | 2/16/2024 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,250 | — | 2/14/2024 | View on chart |
| HON | ▼ Sell | Tax Withholding | 570 | $111K | 2/14/2024 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,307 | — | 2/11/2024 | View on chart |
| HON | ▼ Sell | Tax Withholding | 596 | $116K | 2/11/2024 | View on chart |
| HON | ▲ Buy | Option Exercise | 2,044 | — | 10/3/2023 | View on chart |
| HON | ▼ Sell | Tax Withholding | 909 | $165K | 10/3/2023 | View on chart |
| HON | ▲ Buy | Option Exercise | 23,107 | $2.3M | 5/3/2023 | View on chart |
| HON | ▼ Sell | Tax Withholding | 16,660 | $3.3M | 5/3/2023 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,206 | — | 2/26/2023 | View on chart |
| HON | ▼ Sell | Tax Withholding | 537 | $103K | 2/26/2023 | View on chart |
| HON | ▲ Buy | Grant | 9,751 | $0 | 2/14/2023 | View on chart |
| HON | ▼ Sell | Tax Withholding | 4,352 | $874K | 2/14/2023 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,164 | — | 2/12/2023 | View on chart |
| HON | ▼ Sell | Tax Withholding | 532 | $106K | 2/12/2023 | View on chart |
| HON | ▲ Buy | Option Exercise | 2,057 | — | 7/31/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 915 | $175K | 7/31/2022 | View on chart |
| HON | ▲ Buy | Option Exercise | 21,007 | $1.9M | 7/28/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 14,845 | $2.8M | 7/28/2022 | View on chart |
| HON | ▼ Sell | Open Market | 5,011 | $952K | 7/28/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 2,255 | $421K | 2/26/2022 | View on chart |
| HON | ▲ Buy | Grant | 5,044 | $0 | 2/26/2022 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,199 | — | 2/14/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 549 | $102K | 2/14/2022 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,903 | — | 10/3/2021 | View on chart |
| HON | ▼ Sell | Tax Withholding | 851 | $183K | 10/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MiniMed completes separation from Medtronic
Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.
MiniMed completes separation from Medtronic. Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.